Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The tumor interstitial space is the compartment within solid tumors located outside blood and lymphatic vessels and parenchymal cells, defined by the extracellular matrix (mostly collagen, elastin, glycosaminoglycans) and the interstitial fluid (tumor interstitial fluid). It is the principal medium for the transport of nutrients, waste, drugs, and signaling molecules between cells and capillaries. The composition and organization of the tumor interstitium affect the diffusion of macromolecules, the migration and behavior of cancer and stromal cells, and are a central barrier to the uniform delivery of therapeutic agents to tumors. The structure and biochemical milieu of this space differ markedly from normal tissue interstitium and contribute to tumor pathophysiology, including growth, invasion, and metastasis.
Modification of the tumor interstitial space is sometimes attempted (e.g., by collagenase, hyaluronidase, or stroma-modifying agents) to enhance drug delivery No direct pharmacological mechanism against the space itself
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tumor interstitial space.